Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

53 results about "Site-specific recombination" patented technology

Site-specific recombination, also known as conservative site-specific recombination, is a type of genetic recombination in which DNA strand exchange takes place between segments possessing at least a certain degree of sequence homology. Site-specific recombinases (SSRs) perform rearrangements of DNA segments by recognizing and binding to short DNA sequences (sites), at which they cleave the DNA backbone, exchange the two DNA helices involved and rejoin the DNA strands. While in some site-specific recombination systems just a recombinase enzyme and the recombination sites is enough to perform all these reactions, in other systems a number of accessory proteins and/or accessory sites are also needed. Multiple genome modification strategies, among these recombinase-mediated cassette exchange (RMCE), an advanced approach for the targeted introduction of transcription units into predetermined genomic loci, rely on the capacities of SSRs.

Methods and compositions for editing a genome with prime editing and a recombinase

Disclosed are constructs, systems, and methodologies using prime editing (PE), twin prime editing (twinPE), or multi-flap prime editing to carry out site-specific and large-scale genetic modification, such as, but not limited to, insertions, deletions, inversions, replacements, and chromosomal translocations of whole or partial genes (e.g., whole gene, gene exons and / or introns, and gene regulatory regions). In certain embodiments, the disclosure provides constructs, systems, and methods using prime editing (PE), e.g., single flap or “classical” PE or twinPE or multi-flap PE, to install one or more target sites for site specific recombination in a target genomic locus (e.g., a specific gene, exon, intron, or regulatory sequence), which may then be acted on by one or more site-specific recombinases to effectuate a large-scale genetic modification, such as an insertions, deletions, inversions, replacements, and chromosomal translocations.
Owner:THE BROAD INST INC

Methods of producing eukaryotic host cells or cell lines for lambda integrase mediated recombination

The present invention relates generally to the field of site-specific DNA recombination mediated by lambda integrase, and more specifically, to a method for producing eukaryotic cells and cell lines comprising a genomic landing pad for lambda integrase-mediated recombination, and methods of using the eukaryotic cells themselves and subsequently their use in lambda integrase mediated recombination and as bioreactors for cell therapy.
Owner:NANYANG TECH UNIV +1

Generation of landing pad cell lines

The present disclosure provides methods of generating landing pad cells for targeted gene integration comprising integrating a landing pad plasmid into the genome of a parent cell at a targeted integration site, for example, using homologous recombination. In one aspect, two site-specific recombination sites (SSRSs) are flanked by a polynucleotide sequence; and two homologous recombination sites are located at the 5'and 3 'ends of the SSRS. Two homologous recombination sites of the landing pad plasmid can be recombined with corresponding homologous recombination sites on the parental plasmid, so that the landing pad plasmid is integrated at an internal position in the parental plasmid. The disclosed methods allow for the generation of high expression cell lines by identifying hotspots for targeted integration in thermal cell lines. The present disclosure also provides cells for generating landing pad cells of the disclosure, as well as kits comprising cells and / or agents for generating landing pad cells of the disclosure. Novel hotspots for targeted integration are also provided.
Owner:BRISTOL MYERS SQUIBB CO

Lentivirus with altered integrase activity

Among other things, provided herein are systems that replace the natural random integration activity of a retrovirus with site-specific integration machinery. This approach allows for a more precise targeting of a gene of interest into a human genome, e.g., for therapeutic purposes. The system may include integration-deficient retrovirus (e.g., lentivirus) (IDLV), in which the natural integration activity has been reduced (e.g., by mutation to the viral integrase polypeptide). Instead, the system may comprise a site-specific recombinase (e.g., a serine recombinase, e.g., a serine integrase) capable of directing insertion of a template DNA, or portion thereof, into a desired site in the human genome.
Owner:FLAGSHIP PIONEERING INNOVATIONS VI LLC

Large serine recombinases and systems and uses thereof

Disclosed herein are engineered LSR sequences, compositions, and uses including in genome-editing systems and therapeutic compositions. The LSRs can facilitate nucleic acid recombination at particular attachment sites, using suitable donor sequences. The disclosed LSRs may be used to site-specifically recombine or integrate nucleic acid sequences for a variety of purposes, including treatment of human diseases.
Owner:STYLUS MEDICINE INC +2

Homologous recombination method

A homologous recombination method of excising a specific DNA sequence from a DNA molecule. The method includes providing the DNA molecule including a pair of target sequences that are a target of a site-specific recombination enzyme and a pair of homologous sequences that are DNA sequences sharing homology with each other. The pair of target sequences are oriented in different directions from each other and arranged on opposite sides of the specific DNA sequence. The pair of homologous sequences are arranged on opposite sides of the specific DNA sequence at positions further outside of the pair of target sequences. The method further includes inducing homologous recombination between the pair of homologous sequences by action of the site-specific recombination enzyme on the DNA molecule so that the specific DNA sequence and the pair of target sequences are excised from the DNA molecule.
Owner:KK TOYOTA CHUO KENKYUSHO +1

Engineered modular recombinase compositions, methods, and systems for site-specific DNA recombination

Disclosed are altered recombinases wherein at least one amino acid is different from a parent, wildtype recombinase and the altered recombinase has improved recombination efficiency towards wild-type and / or pseudo att site sequences relative to the parent, wildtype recombinase. Disclosed are altered modular recombinases comprising binding (or interacting) regions from a different recombinase. Disclosed are methods of modifying the genomes of cells using the altered recombinases, including methods of site-specifically integrating a polynucleotide sequence of interest in a genome of a eucaryotic cell.
Owner:SANGAMO THERAPEUTICS INC

Production of bioscalable nanorods

Disclosed herein is a nanorod production system (NPS) that can be used to produce bioscalable functionalized ready nanorods (BSFnano). The produced nanorod is derived from a filamentous bacteriophage Ff (f1, M13 or fd). The NPS disclosed herein allows for efficient biological production of non-infectious, thermally stable isomorphic protein nanorods comprising modifications that allow for site-specific recombination, chemical and enzymatic attachment of peptide and non-peptide functional groups in an orthogonal fashion. Also disclosed are methods of making and using these nanorods, such as in methods of detecting target molecules.
Owner:매시 벤처스 리미티드

Nucleic acid construct and application thereof

PendingCN119020375AAchieve cycle integrationAvoid the screening stepMicroorganism based processesFermentationSite-specific recombinationGenome
The invention discloses a nucleic acid construct and application thereof. The nucleic acid construct comprises a CcdB-ColEI sequence, and also comprises an attB sequence or an attP sequence of a first site specific recombinase, an attB sequence or an attP sequence of a second site specific recombinase, and an attB sequence and an attP sequence of a third site specific recombinase. According to the nucleic acid construct provided by the invention, under the action of the site-specific recombinase, an exogenous target gene can be integrated onto a genome of a host in one step, so that a tedious screening step is avoided, and time is saved; and circulating integration of exogenous target genes can be realized through the system provided by the invention, and the integration effect is high.
Owner:SHANGHAI TECH UNIV

DNA constructs for genome editing in plants

The present invention provides a DNA construct for expressing a genome editing system in plant cells, which comprises an excised region sandwiched by two recombinase recognition sites arranged in the same direction, a gene encoding a site-specific recombinase that specifically recognizes these recombinase recognition sites is arranged outside the excised region, and the excised region comprises a marker gene divided into a 5' region and a 3' region, and a gene encoding the genome editing system arranged between the 3' region and the 5' region.
Owner:KANEKA CORP

Platform for developing stable mammalian cell lines

This disclosure provides methods and landing pad constructs for generation of parental cell lines suitable for targeted integration. A method is provided by the parental cell line development; this is, the introduction of binding sites of BPV1 E2 protein to landing pad vectors so that expressed BPV1 E2 protein could locate the vector to transcriptionally active region in the genome. Cells with high expression level of reporter genes are selected for the next stage and will be used in the development of cell lines expressing another recombinant protein by recombination mediated cassette exchange (RMCE). Landing pad constructs include recombination target sites for site-specific recombinases, and therefore, it could be replaced with gene-of-interest expression construct containing the same set of recombination target sites. This yields the generation of producer cell lines with less effort compared to traditional cell line development by random integration.
Owner:ICOSAGEN CELL FACTORY

Generation of biologically scalable nanorods

Disclosed herein is a nanorod generation system (NPS) useful for the generation of biologically scalable functionalized nanorods (BSF nanorods). The nanorods generated are derived from the filamentous phage Ff (f1, M13, or fd). The NPS disclosed herein allows for the efficient biological generation of non-infectious, thermostable, homotypic protein nanorods that contain modifications that orthogonally enable site-specific recombination, chemical and enzymatic attachment of peptide and non-peptide functionalities. Also disclosed are methods of generating and using these nanorods, such as in methods for detecting target molecules.
Owner:マッセイ·ベンチャーズ·リミテッド

Method for production of a eukaryotic host cell or cell line for lambda-integrase-mediated recombination

The present invention relates generally to the field of site-specific DNA recombination mediated by lambda integrases, and more specifically to methods of producing eukaryotic cells and cell lines comprising a genomic landing pad for lambda integrase mediated recombination, as well as the eukaryotic cells themselves and subsequent methods of their use for lambda integrase mediated recombination and as bioreactors for cell therapies.
Owner:NANYANG TECH UNIV +1

Homologous recombination method

PendingCN120051569AFungiBacteriaHomologous sequenceSite-specific recombination
In a homologous recombination method in which a specific DNA sequence is deleted from a DNA molecule, the DNA molecule is used as the DNA molecule. A DNA molecule is prepared in which a pair of target sequences, which are targets for a site-specific recombinase, are disposed so as to sandwich a specific DNA sequence therebetween and so as to have different orientations from each other, and a pair of homologous sequences, which are DNA sequences having homology, are disposed on the outside of the pair of target sequences disposed so as to sandwich the specific DNA sequence. The site-specific recombinase is caused to act on a DNA molecule, and a specific DNA sequence and a pair of target sequences are deleted from the DNA molecule by homologous recombination between a pair of homologous sequences.
Owner:TOYOTA JIDOSHA KK

Plant regulatory elements and uses thereof for autoexcision

Recombinant DNA molecules and constructs are provided that are useful for modulating gene expression in plants. One or more expression cassette(s) of a recombinant DNA molecule or construct may be excised from transgenic plants following transformation by the presence of flanking site-specific recombination sites in the recombinant DNA molecule or construct by expression of a recombinase enzyme encoded by the recombinant DNA molecule or construct. Such a recombinase system may be used to remove such expression cassette(s) from plants transformed with the recombinant DNA construct or vector. The recombinase transgene may be operably linked to a tissue-preferred or tissue-specific promoter for autoexcision in transformed plants without crossing to a different transgenic line expressing the recombinase. Methods for causing autoexcision of one or more expression cassette(s) in a transgenic plant, and plants and cells containing or transformed with a recombinant DNA molecule or construct of the present disclosure, are also provided.
Owner:MONSANTO TECHNOLOGY LLC

Method for the introduction of genetic information in cell by site-specific integration system

The present invention relates to a method for integrating one or more recombinant sites in a sole target gene of a cell genome comprising carrying out sequentially multiple site-specific recombination by using alternatively two different serine-integrases, wherein the selection marker is removed after each site-specific recombination by different transposases: An in vitro method for inserting at least one recombinant site in a target gene / locus from an isolated cell genome, said method comprising integrating a nucleotide sequence A into the target gene from an isolated cell genome by homologous recombination, wherein said nucleotide sequence A comprises a recombination cassette, flanked at 5′ and 3′ by target gene homology arms, and removing the selection marker by using the second transposase, thus obtaining a cell genome A comprising (i), (ii) and (iii) of nucleotide sequence A.
Owner:CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Plant regulatory elements and uses thereof for autoexcision

Recombinant DNA molecules and constructs are provided that are useful for modulating gene expression in plants. One or more expression cassette(s) of a recombinant DNA molecule or construct may be excised from transgenic plants following transformation by the presence of flanking site-specific recombination sites in the recombinant DNA molecule or construct by expression of a recombinase enzyme encoded by the recombinant DNA molecule or construct. Such a recombinase system may be used to remove such expression cassette(s) from plants transformed with the recombinant DNA construct or vector. The recombinase transgene may be operably linked to a tissue-preferred or tissue-specific promoter for autoexcision in transformed plants without crossing to a different transgenic line expressing the recombinase. Methods for causing autoexcision of one or more expression cassette(s) in a transgenic plant, and plants and cells containing or transformed with a recombinant DNA molecule or construct of the present disclosure, are also provided.
Owner:MONSANTO TECHNOLOGY LLC

Site-specific recombinases for efficient and specific genome editing

The present invention relates generally to the field of genome editing, provides methods for producing DNA recombinases that efficiently and specifically recombine genomic target sequences with obligate DNA recombinase enzymes, and provides DNA recombinases. More specifically, the present invention provides an engineered DNA recombinase for efficient and specific genome editing, comprising an obligate complex of recombinase, said complex comprising at least a first recombinase enzyme and at least a second recombinase enzyme, said first recombinase enzyme and said second recombinase enzyme specifically recognizing a first half-site and a second half-site of an upstream target site and / or a downstream target site of a DNA recombinase, said first recombinase enzyme and said second recombinase enzyme each comprising at least one mutation in a catalytic site, said first recombinase enzyme and said second recombinase enzyme carrying said at least one mutation in a catalytic site do not exhibit catalytic activity of a DNA recombinase when expressed alone, and said catalytic activity as a DNA recombinase is complemented in the obligate complex of recombinase. The present invention further relates to nucleic acid molecules encoding said engineered DNA recombinases and obligate complexes, and to the use of said engineered DNA recombinases and obligate complexes and nucleic acid molecules in pharmaceutical compositions.
Owner:TECHNISCHE UNIVERSITAT DRESDEN

Fusion of site-specific recombinases for efficient and specific genome editing

PendingUS20250243473A1Antibody mimetics/scaffoldsHydrolasesGenome editingX chromosome
The invention relates generally to the field of genome editing and provides DNA recombinases, which efficiently and specifically recombine genomic target sequences via the fusion of recombinase monomers. More specifically, the invention provides a method to generate a fusion protein for efficient and specific genome editing, comprising a complex of recombinases comprising at least a first recombinase enzyme, a second recombinase enzyme and at least one linker, wherein said first recombinase enzyme and said second recombinase enzyme specifically recognize a first half-site and a second half-site of an upstream target site and / or a downstream target site of a recombinase; wherein said first recombinase enzyme and said second recombinase enzyme are interconnected via a linker; and wherein said linker comprises or consists of an oligopeptide. The invention further relates to fusion proteins generated with this method. The invention also discloses designer-recombinases, which catalyze the inversion of a DNA sequence present in the int1h regions on the human X chromosome. The invention further relates to nucleic acid molecules encoding said DNA recombinases and fusion proteins, as well as to the use of said fusion proteins, DNA recombinases and nucleic acid molecules in a pharmaceutical composition.
Owner:TECHNISCHE UNIVERSITAT DRESDEN

Production of biological scalable nanorods

Disclosed herein are nanorod productions systems (NPS) useful for the production of biological scalable functionalization-ready nanorods (BSFnano). The nanorods produced are derived from filamentous phage Ff (f1, M13 or fd). The NPS disclosed herein permits efficient biological production of non-infectious, heat-stable isomorphic proteinaceous nanorods comprising modifications allowing site-specific recombinant, chemical and enzymatic attachment of peptide and non-peptide functionalities in an orthogonal manner. Also disclosed are methods of making and using these nanorods, such as in methods of detecting target molecules.
Owner:MASSEY VENTURES LTD

Methods for creating synthetic chromosomes expressing biosynthetic pathways and uses thereof

To provide compositions and methods capable of delivering and expressing multiple genes from a biosynthetic pathway in a recipient cell using a synthetic chromosome.SOLUTION: A method comprises: transfecting a recipient cell line with synthetic chromosome production components including nucleic acid sequences that allow site-specific integration of target nucleic acid sequences; producing a synthetic platform chromosome with multiple site-specific recombination sites; transfecting the recipient cell line with a delivery vector including multiple genes having the ability to realize a biosynthetic pathway; activating site-specific recombination between the synthetic platform chromosome and the delivery vector, so that the multiple genes having the ability to realize the biosynthetic pathway are loaded onto the synthetic platform chromosome to produce a synthetic chromosome expressing the biosynthetic pathway; and isolating a recipient cell including the synthetic chromosome expressing the biosynthetic pathway.SELECTED DRAWING: None
Owner:CARRYGENES BIOENGINEERING LLC

Screening method of recombinase site variant

The invention relates to the field of molecular biology, and discloses a method for rapidly screening recombinase site variants. An expression vector pUCBN comprising a Bxb1 recombinase expression cassette, a 35S promoter and an attP site located at the downstream of the 35S promoter is constructed, the plasmid and an attB site fragment subjected to PCR amplification are co-transformed into a protoplast, the attB site and the attP site are specifically recognized by utilizing serine recombinase Bxb1 to generate site-specific recombination, recombination between the vector and the fragment is achieved, and the expression vector pUCBN is obtained. Therefore, the recombinase recognition site variant is rapidly screened. Compared with a conventional method for screening recombinase sites by respectively constructing an attB site and an attP site on two vectors, the method has the advantages that the step of frequently constructing the vectors is omitted, a large amount of time and cost are saved, the method is also suitable for high-throughput screening research, recognition sites of Bxb1 recombinase can be rapidly screened in cotton, and the method is suitable for popularization and application. And a basis is provided for widening the application of the serine recombinase Bxb1 in cotton.
Owner:SANYA NATIONAL INSTITUTE OF SOUTHERN BREEDING CHINESE ACADEMY OF AGRICULTURAL SCIENCES +1

Plant regulatory elements and uses thereof for autoexcision

Recombinant DNA molecules and constructs are provided that are useful for modulating gene expression in plants. One or more expression cassette(s) of a recombinant DNA molecule or construct may be excised from transgenic plants following transformation by the presence of flanking site-specific recombination sites in the recombinant DNA molecule or construct by expression of a site-specific recombinase enzyme encoded by the recombinant DNA molecule or construct. Such a recombinase system may be used to remove expression cassette(s) from plants transformed with the recombinant DNA construct or vector. The recombinase transgene may be operably linked to a promoter suitable for autoexcision in transformed plants without crossing to a different transgenic line expressing the recombinase. Methods for causing autoexcision of one or more expression cassette(s) in a transgenic plant, and plants and cells containing or transformed with a recombinant DNA molecule or construct of the present disclosure, are also provided.
Owner:MONSANTO TECHNOLOGY LLC

Engineered modular recombinase compositions, methods, and systems for site-specific DNA recombination

Disclosed are altered recombinases wherein at least one amino acid is different from a parent, wildtype recombinase and the altered recombinase has improved recombination efficiency towards wild-type and / or pseudo att site sequences relative to the parent, wildtype recombinase. Disclosed are altered modular recombinases comprising binding (or interacting) regions from a different recombinase. Disclosed are methods of modifying the genomes of cells using the altered recombinases, including methods of site-specifically integrating a polynucleotide sequence of interest in a genome of a eucaryotic cell.
Owner:SANGAMO THERAPEUTICS INC

Bacillus zonalis phage and uses thereof

The application discloses a corynebacterium striatum phage and application thereof. The corynebacterium striatum phage is a corynebacterium striatum phage CSP1, the preservation number of which is CGMCC NO: 45598, and the preservation time is July 4, 2023. The corynebacterium striatum phage has strong tolerance, biological safety and carries site-specific recombination functional elements (integrase and recombination sites). Meanwhile, the corynebacterium striatum phage can lyse 20 strains of multi-drug resistant corynebacterium striatum, and lays a foundation for subsequent medical researches using the corynebacterium striatum phage as a test and treatment carrier, a targeted pathogenic bacterium or symbiotic bacterium, and an immune regulator inducer.
Owner:HUBEI UNIV OF ARTS & SCI

Highlight-induced photosynthetic electron transfer loop based on recombinase and application

The invention discloses a recombinase-based highlight induced photosynthetic electron transfer loop and application thereof, the loop uses a highlight induced ELIP1 promoter to drive FLP recombinase expression, and regulates and controls the expression of a photosynthetic electron transfer key component gene PETE or PETC through an FLP / FRT site specific recombination system. The problem of light inhibition caused by overload of a plant photosynthetic electron transfer chain in a highlight environment is solved, light intensity dependent gene expression regulation and control are realized, the photosynthetic electron transfer characteristic under highlight stress is effectively improved, and the photoadaptability and photosynthetic efficiency of plants are enhanced. The system provides a new tool for crop stress resistance molecular breeding and synthetic biology research.
Owner:SANYA INST OF HENAN UNIV +1

Process

The present disclosure relates to a novel screening method for screening a plurality of pGREs in parallel and nucleotide constructs for use in the method. The construction body comprises a nucleotide block, the sequence of the nucleotide block is PRIMREG1-pGREE-PRIMREG2-GENEE or GENE-PRIMREG1-pGREE-PRIMREG2, and the PRIMREG1 is a primer recognition sequence 1 or an FLEx box containing the primer recognition sequence 1. PGRE is a presumed gene regulatory element, PRIMREG2 is a primer recognition sequence 2 or a FLEx cassette comprising a primer recognition sequence 2, GENE comprises nucleotide blocks REPSEQ, IRES and SSR, where REPSEQ is a reporter gene and is present or absent, IRES is an internal ribosome entry site or a 2A self-cleaving peptide, and SSR is a site-specific recombinase gene. At least one of the PRIMREG1 and the PRIMREG2 is a FLEx cassette comprising a primer recognition sequence.
Owner:SANIA RX LTD

Plant regulatory elements and uses thereof for autoexcision

Recombinant DNA molecules and constructs are provided that are useful for modulating gene expression in plants. One or more expression cassette(s) of a recombinant DNA molecule or construct may be excised from transgenic plants following transformation by the presence of flanking site-specific recombination sites in the recombinant DNA molecule or construct by expression of a site-specific recombinase enzyme encoded by the recombinant DNA molecule or construct. Such a recombinase system may be used to remove expression cassette(s) from plants transformed with the recombinant DNA construct or vector. The recombinase transgene may be operably linked to a promoter suitable for autoexcision in transformed plants without crossing to a different transgenic line expressing the recombinase. Methods for causing autoexcision of one or more expression cassette(s) in a transgenic plant, and plants and cells containing or transformed with a recombinant DNA molecule or construct of the present disclosure, are also provided.
Owner:MONSANTO TECHNOLOGY LLC

Recombinant plasmid for promoting tylosin synthesis, engineering bacterium and construction method and application thereof

The invention belongs to the technical field of bioengineering, and particularly relates to a recombinant plasmid for promoting synthesis of tylosin, an engineering bacterium and a preparation method thereof, the genetically engineered bacterium (Streptomyces fradiae G3-F2) is preserved in China Center for Type Culture Collection on February 24, 2025, and the preservation number is CCTCC NO: M 2025278. According to the streptomyces fradiae G3-F2 disclosed by the invention, through site-specific recombination, a recombinant plasmid is constructed by utilizing an optimized ZouA gene DNA amplification system, so that multi-copy increase of a tylF gene is realized, and further, streptomyces fradiae G3-F2 is prepared; the enzymatic reaction rate of the methyltransferase is greatly improved; the efficient conversion of the component C is realized; and low-temperature culture fermentation is combined, so that the tylosin synthesis rate and efficiency are greatly improved. The titer of the strain in a 50L tank can reach 18500U / mL under the low-temperature culture condition of 28 DEG C, so that the production cost can be greatly reduced.
Owner:HUAZHONG AGRI UNIV +1

method

The present disclosure relates to a novel screening method to screen multiple pGREs in parallel and to nucleotide construct for use in the method The constructs comprising nucleotide blocks, in sequence PRIMREG1-pGRE-PRIMREG2-GENE, or GENE-PRIMREG1-pGRE-PRIMREG2 wherein PRIMREG1 is either a primer recognition sequence 1, or a FLEx cassette comprising a primer recognition sequence 1. pGRE is a putative gene regulatory element, PRIMREG2 is either a primer recognition sequence 2, or a FLEx cassette comprising a primer recognition sequence 2, GENE comprises nucleotide blocks REPSEQ, IRES and SSR, wherein REPSEQ is a reporter gene and is either present or absent, IRES is either an internal ribosome entry site or a 2A self-cleaving peptide, and SSR is a site specific recombinase gene. At least one of PRIMREG1 and PRIMREG2 is a FLEx cassette comprises a primer recognition sequence.
Owner:SANIA RX LTD